Serum levels of VEGF-A were found to be lower in young patients with ACS compared to the control group, although this difference was statistically nonsignificant. This finding implies a relationship between low levels of VEGF-A and an increased risk of ACS in young individuals.
Ocak et al. (Thu,) studied this question.